- Email:
Neuronal Progenitor Differentiation Services
Introduction
Neuronal progenitor differentiation directs pluripotent stem cells to form region-specific neural stem cells for CNS research. Maintaining lineage integrity is essential for reliable disease modeling. Creative Biolabs offers optimized differentiation services using dual-SMAD inhibition and patterned morphogen protocols to generate high-purity, lineage-specific neural progenitors. The service shortens developmental cycles, supports stable disease modeling, and provides high-quality cells for neurodevelopmental and neurodegenerative drug discovery.
Discover How We Can Help - Request a Consultation
Neuronal Progenitor Differentiation Service
Neuronal Progenitor Cells (NPCs) are multipotent stem cells that can self-renew and differentiate into various functional neuronal subtypes, supporting neurodevelopmental research, disease modeling, and regenerative medicine. Our service uses human iPSCs/ESCs and optimized protocols to generate high-purity, functional NPCs and specific neuronal subtypes with high translational value.
Fig.1 The differentiation trajectories of neurons, astrocytes, and oligodendrocytes.1
Sensory Neuron Progenitor Differentiation
Induced via Notch, Wnt, and BMP signaling activation, sensory neuron progenitors (BRN3A, ISL1, RUNX1-positive) mature into functional sensory neurons, applicable to sensory system research and disorders like peripheral neuropathy.
GABAergic Neuron Progenitor Differentiation
Generated by dual SMAD inhibition plus Shh/FGF modulation, GABAergic progenitors (DLX1/2, GAD65/67, LHX6-positive) support region-specific GABAergic neuron production, facilitating modeling of epilepsy, schizophrenia, and autism.
Dopaminergic Neuron Progenitor Differentiation
Targeted via Shh, FGF8, and Wnt1 signaling, midbrain DA progenitors (FOXA2, LMX1A, NURR1-positive) mature into TH-positive DA neurons, ideal for PD modeling, drug screening, and cell replacement therapy research.
Cholinergic Neuron Progenitor Differentiation
Induced by NGF, BDNF, and RA signaling regulation, cholinergic progenitors (CHAT, VAChT, ISL1-positive) support AD, myasthenia gravis, and cholinergic degeneration research.
Cerebral Cortical Neuron Differentiation
Using feeder-free systems and FGF/BMP/Wnt regulation, cortical progenitors (PAX6, TBR2, CUX1-positive) recapitulate cortical layer formation, enabling research on cortical development, stroke, and microcephaly.
Striatal Neuron Differentiation
Generated via Shh, BMP, and Wnt modulation, striatal progenitors (CTIP2, FOXP2, DARPP-32-positive) mature into MSNs, facilitating HD modeling, mutant HTT studies, and therapeutic validation.
Motor Neuron Differentiation
Induced via RA and Shh activation, motor neuron progenitors (ISL1, HB9, CHAT-positive) mature into functional motor neurons, applicable to ALS, SMA, and motor neuron degeneration research.
All services include strict quality control (marker detection, functional assessment, contamination screening) and customized protocols, bridging basic research and preclinical application.
Workflow
The service process is designed for maximum transparency and scientific rigor, ensuring that the final cellular products meet your exact experimental specifications.
What We Can Offer
At Creative Biolabs, we recognize that every neurological research project has unique requirements. We offer a robust suite of customized differentiation solutions designed to meet the highest standards of the biopharmaceutical industry.
Our Advantage
One-stop Neuronal Differentiation Service
From initial PSC induction to large-scale progenitor expansion and terminal maturation.
Customized Lineage Patterning
Tailored morphogen gradients to generate rare or specific neuronal subtypes beyond standard catalogs.
High-Throughput Scalability
Ability to produce over 100 million synchronized progenitors per batch for large-scale compound libraries.
Rigorous Lineage Validation
Utilization of single-cell transcriptomics and FACS-based purification to guarantee >90% population purity.
Advanced Disease Modeling Support
Integrated CRISPR/Cas9 services for isogenic pair development and ROS-sensitivity assays.
Optimized Cryopreservation Techniques
Specialized freezing protocols ensuring >85% viability and immediate post-thaw recovery for assay readiness.
GMP-Compliant Documentation
Detailed SOPs and process analytical techniques (PAT) used throughout the differentiation lifecycle.
Strategic Consultation
Direct access to our PhD-level neurobiology experts to optimize your differentiation kinetics and experimental design.
Experience the Creative Biolabs Advantage - Get a Quote Today
Customer Reviews
FAQs
Q: How do you ensure the progenitors don't lose their regional identity during expansion?
A: We utilize a combination of continuous morphogen support and metabolic selection. For specific lineages like LMX1A+ midbrain cells, we offer FACS-based purification to ensure that non-patterned cells do not outcompete your target population.
Q: Can you provide isogenic control lines for my differentiation project?
A: Yes. Creative Biolabs offers CRISPR/Cas9 gene editing to create isogenic pairs (e.g., wild-type and disease-mutant) from the same genetic background, eliminating the noise caused by donor-to-donor variability.
Q: What is the typical purity level of the delivered progenitors?
A: Our standard deliverables exceed 90% purity for pan-neural markers (Nestin/Sox2) and typically achieve >85% purity for lineage-specific markers, depending on the complexity of the subtype.
Q: Are these cells suitable for 3D organoid formation?
A: Yes. Our progenitors are optimized for high-density culture and are frequently used as the starting material for brain spheroids, organoids, and BBB-on-chip models.
Q: How are the cells shipped?
A: Cells are typically shipped cryopreserved in dry ice. We provide detailed thawing and maturation protocols to ensure a high recovery rate upon arrival at your facility.
Creative Biolabs offers a suite of Neuronal Progenitor Differentiation services, from initial cell line induction to high-purity regional patterning and functional validation. Our platform is designed to provide the consistency and biological relevance required for the next generation of CNS therapeutics.
Contact Our Team for More Information and to Discuss Your Project
Reference
- Shigenaka, Aki, et al. "Defective Neural Stem and Progenitor Cell Proliferation in Neurodevelopmental Disorders." Journal of Developmental Biology 13.4 (2025): 40. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/jdb13040040.
For Research Use Only. Not For Clinical Use.